Toxicities Associated with PARP Inhibitors in Ovarian Cancer

preview_player
Показать описание
Ursula A. Matulonis, MD, professor of Medicine, Harvard Medical School, medical director of Gynecologic Oncology, Dana-Farber Cancer Institute, discusses the toxicities that are associated with PARP inhibitors in ovarian cancer.
  1. Targeted Oncology
  2. targeted oncology
  3. oncology
  4. cancer
Рекомендации по теме
Toxicities Associated with 0:02:31

Toxicities Associated with PARP Inhibitors in Ovarian Cancer

PARP Inhibitor Toxicity 0:07:14

PARP Inhibitor Toxicity Management

Dr. O'Malley on 0:01:11

Dr. O'Malley on Toxicity Profiles of PARP Inhibitors in Ovarian Cancer

Dr. Secord on 0:00:59

Dr. Secord on Financial Toxicity Associated With PARP Inhibition

Toxicities Associated With 0:02:15

Toxicities Associated With Rucaparib for the Treatment of Ovarian Cancer

Dr. Matulonis on 0:02:30

Dr. Matulonis on Toxicities With PARP Inhibitors in Ovarian Cancer

Managing PARP Inhibitor 0:03:05

Managing PARP Inhibitor Toxicities in Ovarian Cancer

PARP Inhibitors in 0:08:03

PARP Inhibitors in Ovarian Cancer: Safety Profile

Dr. Coleman Discusses 0:01:36

Dr. Coleman Discusses the Toxicities Associated With Rucaparib in Patients With Ovarian Cancer

SOLO3 Highlights Toxicities 0:01:11

SOLO3 Highlights Toxicities With Olaparib in Ovarian Cancer

PARP Inhibitor Costs 0:01:56

PARP Inhibitor Costs Give Patients With Ovarian Cancer Financial Toxicity

Difference Among PARP 0:06:39

Difference Among PARP Inhibitors for Ovarian Cancer

PARP Inhibitors for 0:34:17

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

PARP Inhibitors: Assessing 1:02:31

PARP Inhibitors: Assessing the Clinical Trial Landscape

PARP Inhibitors: Which 0:09:17

PARP Inhibitors: Which One Should We Use?

The Advanced Ovarian 1:29:06

The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP Inhibitors

Role of PARP 0:16:22

Role of PARP Inhibitors in Prostate Cancer

Understand the Adverse 0:00:41

Understand the Adverse Events of PARP Inhibitors

Dr Timothy Yap: 0:01:17

Dr Timothy Yap: PARP/TOP1 Inhibitor Toxicities Can Be Managed Through Targeted Delivery

PARP Inhibitors for 0:05:19

PARP Inhibitors for BRCA-Associated TNBC

PARP inhibitors for 0:03:45

PARP inhibitors for ovarian cancer

PARP Inhibitor Side 0:06:35

PARP Inhibitor Side Effect Management in Ovarian Cancer

Management of PARP 0:05:38

Management of PARP Inhibitor AEs in Ovarian Cancer

Understanding the Side 0:06:31

Understanding the Side Effects of PARP Inhibitors